openPR Logo
Press release

Hydrate Inhibitors Market Industry Insights and Growth 2025

04-16-2018 08:50 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Hydrate Inhibitors Market

North America is the largest market for hydrate inhibitors. This is primarily due to extreme high pressures and 40OF temperature in the Gulf of Mexico which is a large oil producing zone. Wells in Alaska also require the use of hydrate inhibitors. Kaikias deep-water in the Gulf of Mexico is currently in Appraisal Phase and will be commissioned by 2020.

Middle East and Africa is also showing a significant growth in hydrate inhibitors market due to the substantial number of hydrate threatened wells. Saudi Arabia controls the world’s largest offshore oil field and Qatar is the largest producer of LNG in the world. The largest gas field in the world is also present in this region.

Sample Copy of This Report@ https://www.coherentmarketinsights.com/insight/request-sample/555

Europe is the next largest market with conditions conducive to hydrate formation present in oil fields of North Sea and Russia. With increased exploration and drilling in the Arctic where sub-zero temperatures are the norm, hydrate inhibition shows vital performance which will drive the hydrate inhibitors market.

Asia Pacific market is expected to augment market growth in the near future, as exploration in the offshore regions of Bay of Bengal, South China Sea and Indian Ocean gains momentum. The emerging countries of this region such as India, China, Indonesia are highly dependent on oil imports from Middle East, ramped up exploration activity is due to a need to become energy independent. In June 2017, Reliance and BP sanctioned further development in KG Basin with an investment of US$ 6 billion.

Latin America is projected to witness an increase in hydrate inhibitor market as oil production moves to deep and ultra-deep-water zones due to depletion of onshore reserves. Exploiting the reserves of Santos basin off the coast of Brazil will require hydrate inhibition due to low temperatures on the Atlantic seabed. This will boost hydrate inhibitors market in the region. Chile and Argentina are expected to follow suit in exploiting offshore reserves.

The environmental concerns regarding methanol, which is a toxic chemical, have led to development of newer hydrate inhibition methods such as Low Dosage Hydrate Inhibitors and use of MEG instead of Methanol. This switch has had environmental, technical and economic perks. Major players in the hydrate inhibitor market are Ashland, Halliburton, NALCO (ECOLAB COMPANY), Woodview Technology, BASF, NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Mar, LEWA

Hydrate Inhibitors Market Taxonomy

On basis of Inhibitor Type

Thermodynamic Inhibitors,Methanol,Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s): Anti-Agglomeration Inhibitors/Surfactants, Quaternary Ammonium Compounds,Amides, Bio-surfactants

Kinetic Inhibitors: Polyvinylcaprolactam, Polyvinylpyrrolidone, Polyethyloxazoline, N-methyl-N-vinylacetamide, Tetra pentyl ammonium bromide, Butoxy-ethanol, Emulsifiers, Hybrid, Others

Thermodynamic inhibitors on addition shift the thermodynamic equilibrium and disrupting hydrate formation. Methanol and MEG are most commonly used. MEG can be regenerated and is more cost effective. Methanol though cheaper on volume basis cannot be regenerated and is not environment friendly as well.

To get detailed table of content (ToC)@ https://www.coherentmarketinsights.com/ongoing-insight/toc/555

Low Dosage Hydrate Inhibitors are used when large concentrations of thermodynamic inhibitors are required, making their use uneconomical. They do not disturb thermodynamic equilibrium, instead affect the hydrate growth. Anti-Agglomeration Agents prevent the agglomeration of hydrate crystals by disrupting hydrate growth process and transportable slurry is formed. These inhibitors are typically used below a 50% water cut level. Kinetic Inhibitors prevent nucleation, so the produced fluid is transported further to downstream before hydrate formation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights
1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hydrate Inhibitors Market Industry Insights and Growth 2025 here

News-ID: 1017047 • Views:

More Releases from Hydrate Inhibitors Market

Hydrate Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Hydrate Inhibitors Market - Global Industry Insights, Trends, Outlook, and Oppor …
Hydrate Inhibitors are used to prevent or reduce gas hydrate formation. Gas Hydrates are formed in offshore production systems under low temperature and high pressure conditions. The hydrates block the pipelines, drill strings, BOP’s, by forming plugs and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. Subsea equipment such as pipelines, risers, Christmas trees, jumpers and

More Releases for Inhibitor

Advances in KRAS Inhibitor Development
The development of KRAS inhibitors has been a significant advancement in the field of oncology, offering new hope for patients with cancers driven by KRAS mutations. KRAS, a key gene involved in cell signaling, is frequently mutated in various cancers, including lung, colorectal, and pancreatic cancers. These mutations lead to uncontrolled cell growth and division, making KRAS a critical target for cancer therapy. Download Report: https://www.kuickresearch.com/report-kras-inhibitors-market-lumakras-sales-kras-drugs-market-kras-market-size Historically, KRAS was considered an undruggable target
Breakthroughs in KRAS Inhibitor Research
KRAS mutations have posed a significant challenge in oncology for decades, but recent breakthroughs in KRAS inhibitor research have sparked hope for new cancer therapies. KRAS is a key regulator of cell growth and survival, and its mutations are prevalent in various cancers, particularly lung, colorectal, and pancreatic cancers. Despite being one of the most sought-after targets, KRAS has been notoriously difficult to inhibit, earning the reputation of being "undruggable." Download
Checkpoint Inhibitor Refractory Cancer Market
Checkpoint Inhibitor Refractory Cancer Market Overview The global Checkpoint Inhibitor Refractory Cancer Market is poised for significant growth, anticipating a high CAGR during the forecast period from 2023 to 2030. Understanding Checkpoint Inhibitor Refractory Cancer Refractory cancer, which might not respond to treatments immediately or might develop resistance later, has driven significant growth and transformation in the global checkpoint inhibitor refractory cancer market. The interest of oncologists in the potential antitumor activity of
Fibroblast Growth Factor Receptor Inhibitor Market - Maximizing Therapeutic Pote …
Newark, New Castle, USA: The "Fibroblast Growth Factor Receptor Inhibitor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Fibroblast Growth Factor Receptor Inhibitor Market: https://www.growthplusreports.com/report/fibroblast-growth-factor-receptor-inhibitor-market/8933 This latest report
Global Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) Market Forecast 2023- …
The global Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) market research report helps target customers understand the important driving factors and future opportunities of the industry. The report includes the dynamics of the macro environment such as the latest situation of the war between Russia and Ukraine, the update of monetary policy, and the impact of inflation on the market. Apart from this, the report studies key market developments such as
Avionic and electronic component corrosion inhibitor
Super CORR A was originally developed for the U.S. Air Force to comply with Mil-DTL-87177B (formerly Mil-L-87177A) specifications. A water displacing lubricant and corrosion protection compound that prevents avionic as well as electrical and electronic components from systems failures caused by corrosion. It is now the industry standard for electrical corrosion protection, for in service maintenance by both military and commercial aircraft major repair and overhaul (MRO) facilities worldwide. Super CORR